论文部分内容阅读
目的:探讨氨溴索治疗老年慢性支气管炎急性发作的疗效。方法:选择68例老年慢性支气管炎患者随机分为治疗组和对照组。两组均予吸氧、解痉、平喘及控制感染等基础治疗。治疗组在此基础上同时予氨溴索注射液1次15~30mg,1日2次,静脉滴注;疗程1周。比较两组的的临床疗效及不良反应。结果:治疗后,治疗组的临床总有效率94.12%,明显高于对照组(P<0.05)。结论:氨溴索治疗老年慢性支气管炎急性发作安全有效,是一种理想药物,值得推广和应用。
Objective: To investigate the efficacy of ambroxol in the treatment of acute exacerbation of senile chronic bronchitis. Methods: Sixty-eight elderly patients with chronic bronchitis were randomly divided into treatment group and control group. Both groups were to oxygen, spasm, asthma and infection control and other basic treatment. The treatment group on the basis of this simultaneously to ambroxol injection once 15 ~ 30mg, 1 2 times, intravenous infusion; course of treatment for 1 week. The clinical efficacy and adverse reactions of the two groups were compared. Results: After treatment, the total effective rate of the treatment group was 94.12%, which was significantly higher than that of the control group (P <0.05). Conclusion: Ambroxol is safe and effective in the treatment of acute exacerbation of chronic bronchitis in the elderly. It is an ideal drug that deserves promotion and application.